Pancreatic cancer clinical trials exclude Black patients bas

A simulated pancreatic cancer clinical trial screening process showed that Black patients were significantly more likely than white patients to be excluded from clinical trials for a wide range of eligibility criteria, according to results presented at the virtual 14th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved, held October 6-8, 2021.

Related Keywords

Virginia , United States , Richmond , Joseg Trevino , Andrean Riner , Emily Henderson , Massey Cancer Center Informatics Core , National Human Genome Research Institute Riner , National Cancer Institute Riner , University Of Florida , Drug Administration , Massey Cancer Center , Cancer Health Disparities , Ethnic Minorities , Medically Underserved , Cancer Center , Research Fellow , General Surgery Resident , National Human Genome Research Institute , National Cancer Institute , Cancer Center Informatics Core , Ann Matella Fund , Pancreatic Cancer Research , Cancer , Clinical Trial , Pancreatic Cancer , Adenocarcinoma , Albumin , Cancer Treatment , Chemotherapy , Efficacy , Wood , Health Disparities , Hepatitis , Hepatitis B , Hepatitis C , Shiv , Nutrition , Research , Surgery , Herapeutics ,